Neuroendocrine Tumours: Diagnosis and Management
暫譯: 神經內分泌腫瘤：診斷與管理

本書的第二版涵蓋了神經內分泌腫瘤（NETs）的所有方面，包括流行病學、病理分類與評估、分子生物學，直至診斷影像學方法和治療選擇，包括最新的靶向治療和免疫治療。讀者將會對各種不同類型的神經內分泌腫瘤進行個別討論：如胃腸道腫瘤、肺部腫瘤和胰腺腫瘤，包括胰島素瘤、胃泌素瘤、升糖素瘤、腸抑制素瘤、體抑素瘤、胰腺多肽瘤以及非功能性胰腺神經內分泌腫瘤，還有髓樣甲狀腺癌、嗜鉻細胞瘤、旁神經節瘤等。除了神經內分泌腫瘤外，甲狀腺腫瘤和腎上腺皮質腫瘤等內分泌腫瘤也有涵蓋。參與撰寫的作者是國際公認的專家，為該主題帶來了豐富的科學知識和經驗。本書將成為執業的醫療腫瘤學家、外科醫生、內分泌學家、腸胃病學家和病理學家以及這些領域的實習生的重要資訊來源。

​Kjell Öberg is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University and a former head of the Department of Endocrine Oncology, University Hospital, Uppsala. He is also Adjunct Professor of Surgery at Vanderbilt University, Nashville, Tenn., USA. Dr. Öberg is a specialist in endocrinology and internal medicine with 40 years' experience in the field of neuroendocrine tumors. He was one of the founders and coordinator of the European Neuroendocrine Tumor Network (ENET) (1995-2000), the president of ENETs 2010-2012 and is a past chairman of the Nordic Neuroendocrine Tumor Group. He has pioneered the treatment of carcinoid tumor patients with interferon and somatostatin analogs and developed assays for tumor markers such as chromogranin A and radiological procedures including specialized PET scans. Dr. Öberg has received numerous awards, including most recently the Rudbeck Medallion for excellence in research (2014), a Lifetime Achievement Awardfrom the North American Neuroendocrine Society (2014), The Swedish Endocrine Society Gold Medal for prominent research and clinical activities (2017), and a Lifetime Achievement Award from the European Neuroendocrine Tumor Society (ENETS), of which he has been Vice President since 2012.

Suayib Yalcin is a medical oncologist with a special interest in gastrointestinal cancer treatment and research who is a full professor at Hacettepe University Cancer Institute, Turkey. Dr. Yalcin has served as Director of the Hacettepe University Oncology Hospital and Head of the Hacettepe University Medical Oncology Department. He has held a variety of important posts in medical organizations, including President of Turkish Society of Medical Oncology, General Secretary of Turkish Oncology Group, and National Representative of ESMO in Turkey. Currently he is President of the Turkish Association of Cancer Research and Control and President of Hacettepe Oncology Association.He is an active member of ASCO, ESMO, EORTC, and MMOF. Dr. Yalcin has participated in many clinical cancer research projects as a steering committee member or principal investigator and serves on the editorial board of several cancer journals. He has been the conference chair of the International Gastrointestinal Cancer Conference (www.igicc2017.org) for the past 7 years. He has authored or co-authored more than 100 articles cited in Science Citation Index.

Kjell Öberg 是烏普薩拉大學醫學院內分泌腫瘤學教授，曾任烏普薩拉大學醫院內分泌腫瘤科主任。他同時也是美國田納西州納什維爾范德堡大學的外科副教授。Öberg 博士是內分泌學和內科的專家，擁有 40 年神經內分泌腫瘤領域的經驗。他是歐洲神經內分泌腫瘤網絡（European Neuroendocrine Tumor Network, ENET）的創始人之一及協調員（1995-2000），曾擔任 ENET 的會長（2010-2012），並且是北歐神經內分泌腫瘤小組的前主席。他在治療類癌腫瘤患者方面開創了使用干擾素和生長抑素類藥物的先河，並開發了腫瘤標記物的檢測方法，如嗜鉻粒蛋白 A 及包括專門的 PET 掃描在內的放射學程序。Öberg 博士獲得了多項獎項，包括最近的魯德貝克獎章（Rudbeck Medallion）以表彰其在研究方面的卓越成就（2014），北美神經內分泌學會的終身成就獎（2014），瑞典內分泌學會的金獎以表彰其傑出的研究和臨床活動（2017），以及歐洲神經內分泌腫瘤學會（ENETS）的終身成就獎，自 2012 年以來他一直擔任該會的副會長。

Suayib Yalcin 是一位專注於胃腸道癌症治療和研究的醫學腫瘤學家，現任土耳其哈賽特佩大學癌症研究所的全職教授。Yalcin 博士曾擔任哈賽特佩大學腫瘤醫院的主任及哈賽特佩大學醫學腫瘤科的負責人。他在醫學組織中擔任過多個重要職位，包括土耳其醫學腫瘤學會會長、土耳其腫瘤小組的總秘書，以及土耳其的 ESMO 國家代表。目前，他是土耳其癌症研究與控制協會的會長及哈賽特佩腫瘤協會的會長。他是 ASCO、ESMO、EORTC 和 MMOF 的活躍成員。Yalcin 博士作為指導委員會成員或主要研究者參與了許多臨床癌症研究項目，並在幾本癌症期刊的編輯委員會中任職。他在過去 7 年中擔任國際胃腸道癌症會議（www.igicc2017.org）的會議主席。他已發表或共同發表超過 100 篇被科學引文索引（Science Citation Index）引用的文章。